story of the week
Canagliflozin Improves Renal Outcomes in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
N. Engl. J. Med 2019 Apr 14;[EPub Ahead of Print], V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, DM Charytan, R Edwards, R Agarwal, G Bakris, S Bull, CP Cannon, G Capuano, PL Chu, D de Zeeuw, T Greene, A Levin, C Pollock, DC Wheeler, Y Yavin, H Zhang, B Zinman, G Meininger, BM Brenner, KW MahaffeyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.